title: Recombinant interleukin 2 for metastatic renal cell carcinoma in haemodialysis patients.
authors.forename: J
authors.initials: J
authors.lastname: Buter
authors.forename: R A
authors.initials: RA
authors.lastname: Janssen
authors.forename: N H
authors.initials: NH
authors.lastname: Mulder
authors.forename: P E
authors.initials: PE
authors.lastname: de Jong
authors.forename: L
authors.initials: L
authors.lastname: de Leij
authors.forename: D T
authors.initials: DT
authors.lastname: Sleijfer
mesh_terms: D000368:Aged; D002292:Carcinoma, Renal Cell / Q000556:secondary*; D006801:Humans; D007279:Injections, Subcutaneous; D007376:Interleukin-2 / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000009:adverse effects; D006435:Renal Dialysis
chemical_list: D007376:Interleukin-2; D011994:Recombinant Proteins